Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Public Health ; 113(2): 162-165, 2023 02.
Article in English | MEDLINE | ID: mdl-36480765

ABSTRACT

To determine whether the Veterans Health Administration's (VHA) hepatitis C (HCV) treatment campaign reached marginalized populations, we compared HCV care by previous incarceration status with Veterans Aging Cohort Study data. Of those with and those without previous incarceration, respectively, 40% and 21% had detectable HCV, 59% and 65% underwent treatment (P = .07); 92% and 94% of those who completed treatment achieved sustained virologic response. The VHA HCV treatment effort was successful and other systems should replicate those efforts. (Am J Public Health. 2023;113(2):162-165. https://doi.org/10.2105/AJPH.2022.307152).


Subject(s)
Hepatitis C , Veterans , United States/epidemiology , Humans , Veterans Health , Cohort Studies , United States Department of Veterans Affairs , Hepatitis C/drug therapy , Hepacivirus , Antiviral Agents/therapeutic use
3.
Clin Liver Dis ; 24(3): 453-481, 2020 08.
Article in English | MEDLINE | ID: mdl-32620283

ABSTRACT

Budd-Chiari syndrome (BCS), or hepatic venous outflow obstruction, is a rare cause of liver disease that should not be missed. Variable clinical presentation among patients with BCS necessitates a high index of suspicion to avoid missing this life-threatening diagnosis. BCS is characterized as primary or secondary, depending on etiology of venous obstruction. Most patients with primary BCS have several contributing risk factors leading to a prothrombotic state. A multidisciplinary stepwise approach is integral in treating BCS. Lifelong anticoagulation is recommended. Long-term monitoring of patients for development of cirrhosis, complications of portal hypertension, hepatocellular carcinoma, and progression of underlying diseases is important.


Subject(s)
Budd-Chiari Syndrome/diagnosis , Budd-Chiari Syndrome/therapy , Angioplasty , Anticoagulants/therapeutic use , Budd-Chiari Syndrome/epidemiology , Budd-Chiari Syndrome/etiology , Decompression, Surgical , Humans , Liver Transplantation , Myeloproliferative Disorders/complications , Portasystemic Shunt, Transjugular Intrahepatic , Prognosis , Risk Factors , Stents , Thrombophilia/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...